Taiho Pharmaceutical and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Ty

-FIH Study in EGFR Exon 20 Insertions Will Commence in 2019- TOKYO and CAMBRIDGE, Massachusetts, Feb. 5, 2019 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. ... Lees verder

Bron:

ANP Pers support